| On June 30th, 2020, America Great Health (the “Company”) and Purecell Group (“Purecell”), a leading anti-aging medical institution in Australia, entered into a Cooperation Agreement, in which the Company agreed to acquire 51% of the equity of Purecell, as consideration, the Company shall issue 510,000,000 common shares to Purecell’s nominated trustee. Upon completion of the acquisition transaction, Purecell shall remain autonomy in its day to day operation, including recruiting and retaining management team members. On February 10th, 2021, the Company completed its financial and legal due diligence and consummated the acquisition of Purecell, with total of 510,000,000 common shares transferred to Purecell’s nominated trustee. |
America Great Health (OTC: AAGH) completed the acquisition of 51% equity in Purecell Group
Earlier from America Great Health
- America Great Health entered into a Cooperation Agreement with Brilliant Healthcare Limited to establish a joint venture in China for promoting and developing stem cell related products
- America Great Health(OTC: AAGH) entered into an Asset Purchase Agreement with Chaoyang Tianma
- America Great Health California established a JV with Guangzhou Bona Biotechnology Co., Ltd. for health and cosmetics related products supplied by AAGH California in China
- Corporate changed name and stock symbol from Crown Marketing (CWNM) to America Great Health (AAGH)